Table 3.
n (%) | Median (Range) | Median (Range) | |
---|---|---|---|
NLR | Neutrophils (×109/L) | Lymphocytes (×109/L) | |
<3 | 42 (41.6%) | 4.1 (2.4–6.6) | 2.1 (1.3–6.2) |
3–5 | 30 (29.7%) | 4.9 (2.9–10.2) | 1.4 (0.6–2.9) |
>5 | 29 (28.7%) | 8.7 (4.9–19.7) | 0.9 (0.4–2.7) |
NLS | |||
0 | 39 (38.6%) | 4.8 (2.4–7.4) | 2.1 (1.5–6.2) |
1 | 45 (44.6%) | 4.9 (2.5–15.1) | 1.3 (0.5–2.9) |
2 | 17 (16.8%) | 9.5 (7.9–19.7) | 0.8 (0.4–1.4) |
NPS | Neutrophils (×109/L) | Platelets (×109/L) | |
0 | 74 (73.3%) | 4.5 (2.4–7.4) | 250 (127–396) |
1 | 23 (22.7%) | 9.0 (4.1–19.7) | 277 (137–595) |
2 | 4 (3.9%) | 9.4 (7.6–15.1) | 425 (406–555) |
PLR | Platelets (×109/L) | Lymphocytes (×109/L) | |
≤150 | 42 (41.6%) | 233 (124–406) | 2.1 (0.9–6.2) |
>150 | 59 (58.4%) | 267 (137–595) | 1.2 (0.4–2.9) |
PLS | |||
0 | 40 39.6%) | 267 (168–378) | 2.1 (1.5–6.2) |
1 | 60 (59.4%) | 250 (127–595) | 1.2 (0.4–2.9) |
2 | 1 (0.9%) | - | - |
CAR | Albumin (g/L) | CRP (mg/dL) | |
≤0.22 | 67 (65.7%) | 40 (30–51) | 2.0 (0.0–9.4) |
>0.22 | 35 (34.3%) | 35 (18–46) | 26.5 (6.0–242.0) |
GPS | |||
0 | 59 57.8%) | 40 (31–51) | 2.0 (0.0–8.1) |
1 | 26 (25.5%) | 36 (25–46) | 9.9 (0.3–98.4) |
2 | 17 (16.7%) | 31 (18–35) | 40.7 (10.0–242.0) |
PNI | Albumin (g/L) | Lymphocytes (×109/L) | |
≥50 | 34 (33.7%) | 45 (31–51) | 1.9 (0.8–6.2) |
<50 | 67 (66.3%) | 36 (18–44) | 1.2 (0.4–2.9) |
PI | WBC (×109/L) | CRP (mg/dL) | |
0 | 63 (61.7%) | 7.0 (4.1–10.8) | 2.2 (0.0–40.7) |
1 | 27 (26.5%) | 9.9 (4.8–17.8) | 11.7 (0.6–186.0) |
2 | 12 (11.7%) | 12.5 (10.1–22.3) | 36.6 (12.6–242.0) |
NLR, neutrophil–lymphocyte ratio; NLS, neutrophil–lymphocyte score; NPS, neutrophil–platelet-score; PLR, platelet–lymphocyte ratio; PLS, platelet–lymphocyte score; CAR C, reactive protein albumin ratio; CRP, C-reactive protein; GPS, Glasgow Prognostic Score; PI, prognostic index; PNI, prognostic nutritional index; WBC, white blood cell count.